SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435906. A total of 2 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $244,595,000 | +3011.1% | 1,415,400 | +1969.3% | 3.84% | +3126.9% |
| Q4 2014 | $7,862,000 | -34.4% | 68,400 | -10.8% | 0.12% | -35.7% |
| Q3 2014 | $11,984,000 | +127.0% | 76,700 | +79.2% | 0.18% | +128.4% |
| Q2 2014 | $5,279,000 | +561.5% | 42,800 | +455.8% | 0.08% | +523.1% |
| Q1 2014 | $798,000 | -68.5% | 7,700 | -72.7% | 0.01% | -65.8% |
| Q4 2013 | $2,536,000 | +1546.8% | 28,200 | +1126.1% | 0.04% | +1166.7% |
| Q3 2013 | $154,000 | -81.1% | 2,300 | -81.3% | 0.00% | -85.0% |
| Q2 2013 | $814,000 | – | 12,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 2,300 | $154,000 | 0.00% |
| Citadel Advisors | 11,500 | $769,000 | 0.00% |